WHO

ISN stands with the WHO

The International Society of Nephrology (ISN), with its mission to improve kidney health worldwide and ensure that all people have equitable access to sustainable kidney health, has noted with alarming concern that President Donald Trump has formally moved to withdraw the US from the World Health Organization (WHO). The global healthcare community has appreciated the...

ISN Attends WHO Executive Board Meeting

ISN was invited and pleased to attend the 146th Session of the Executive Board (EB) of the World Health Organization (WHO) from February 3-8, 2020. This year the EB Meeting addressed topics extremely relevant to kidney patients, such as the advancement of primary care and the implementation of the recent Political Declaration on Universal Health...

ISN takes stage at WHO meeting in Geneva

ISN recently participated in the 144th World Health Organization (WHO) Executive Board meeting that took place in Geneva, Switzerland, from January 24 to February 1st, 2019. This was a valuable opportunity to highlight the case of kidney disease worldwide, calling for integrated action on prevention, early detection and management. During the meeting, ISN was asked to...

ISN presence at the World Health Assembly

ISN looks forward to representing the kidney health community at this week’s World Health Assembly in Geneva. Coinciding with the 70th anniversary of the World Health Organization (WHO), this assembly’s program is a busy affair for ISN. Two major agenda points are set to be agreed upon among the WHO member states. This includes the organization’s...

HEARTS: highlighting CKD and CVD prevention

ISN is calling for the implementation of the HEARTS technical package on cardiovascular disease prevention. The World Health Organization and the US Center for Disease Control and Prevention have developed the HEARTS technical package as part of the GLOBAL HEARTS INITIATIVE, of which ISN is a partner. Cardiovascular diseases (CVDs) are the number one cause...

A trusted leader

In January 2012, ISN became the only nephrology society in official relations with the World Health Organization (WHO). How is the ISN community using this opportunity to voice the needs of kidney patients and bridge gaps in global care? For over five years, ISN has put continued efforts into working as a WHO Non-State Actor...

ISN at the WHO in Geneva

Last week, we joined the World Health Organization (WHO) executive board meeting to comment on its 2019-2023 general program of work (GPW). Member States, international NGOs and non-state actors in official relations with WHO shared their views. We lent our support to the strategy’s general principles, which align with the 2030 sustainable development agenda. But,...

WHO announces new Director General

Tedros Adhanom Ghebreyesus has been appointed as World Health Organization (WHO) Director General after receiving a clear majority of the votes from WHO Member States. He will take office on July 1st, 2017. Upon hearing the news, ISN President David Harris stated: ‘I strongly welcome the new Director General and I look forward to a...

ISN contributes to WHO stakeholder consultation on tackling NCDs

In September 2016, ISN was invited to participate to a World Health Organisation (WHO) stakeholder consultation on the revision of Appendix 3 of the WHO NCD Global Action Plan 2013-2020. In the consultation response, ISN stressed the importance of kidney disease as a ’neglected’ disease, which raises important public health concerns worldwide and should be...

ISN participates in high-level WHO meeting in Copenhagen

Last week, ISN joined European health ministers and high-level representatives from 53 Member States at the 66th session of the World Health Organization (WHO) Regional Committee for Europe to discuss the challenges of tackling the burden of non-communicable diseases (NCDs) in Europe. At the meeting, ISN strongly supported the goals and implementation of the 2030...